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There is controversy regarding the inclusion of patients with hypertension among cases of
peripartum cardiomyopathy (PPCM), as the practice has contributed significantly to the dis-
crepancy in reported characteristics of PPCM. We sought to determine whether hyperten-
sive heart failure of pregnancy (HHFP) (i.e., peripartum cardiac failure associated with any
form of hypertension) and PPCM have similar or different clinical features and outcome.
Methods and Results
We compared the time of onset of symptoms, clinical profile (including electrocardiographic
[ECG] and echocardiographic features) and outcome of patients with HHFP (n = 53; age
29.6 ± 6.6 years) and PPCM (n = 30; age 31.5 ± 7.5 years). The onset of symptoms was
postpartum in all PPCM patients, whereas it was antepartum in 85% of HHFP cases
(p<0.001). PPCMwas more significantly associated with the following features than HHFP
(p<0.05): twin pregnancy, smoking, cardiomegaly with lower left ventricular ejection fraction
on echocardiography, and longer QRS duration, QRS abnormalities, left atrial hypertrophy,
left bundle branch block, T wave inversion and atrial fibrillation on ECG. By contrast, HHFP
patients were significantly more likely (p<0.05) to have a family history of hypertension,
hypertension and pre-eclampsia in a previous pregnancy, tachycardia at presentation on
ECG, and left ventricular hypertrophy on echocardiography. Chronic heart failure, intra-car-
diac thrombus and pulmonary hypertension were found significantly more commonly in
PPCM than in HHFP (p<0.05). There were 5 deaths in the PPCM group compared to none
among HHFP cases (p = 0.005) during follow-up.
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Conclusion
There are significant differences in the time of onset of heart failure, clinical, ECG and echo-
cardiographic features, and outcome of HHFP compared to PPCM, indicating that the pres-
ence of hypertension in pregnancy-associated heart failure may not fit the case definition of
idiopathic PPCM.
Introduction
Peripartum cardiomyopathy (PPCM) is defined as a myocardial disorder of unknown cause,
characterized by marked impairment of left ventricular (LV) systolic function, with develop-
ment of heart failure towards the end of pregnancy and in the months following delivery, in
women without pre-existing heart disease, and in the absence of any other identifiable cause of
peripartum heart failure [1,2]. Although the aetiology of PPCM is poorly understood [3,4],
many authorities consider pregnancy-induced hypertension (PIH) to be a risk factor for
PPCM [4–8]. Furthermore, it has been postulated that hypertensive heart failure of pregnancy
(HHFP), defined as the occurrence of peripartum heart failure in association with any form of
hypertension, and PPCMmay represent a spectrum of the same disease which has a common
pathophysiological pathway [9].
Our group has proposed a clear case definition of PPCM, noting that PPCM should be a
diagnosis of exclusion that precludes all other known causes of peripartum heart failure, includ-
ing hypertension [3,10]. Since the seminal description of PPCM by Demakis in 1971, where pre-
eclampsia was found in 22% of the 27 patients studied [5], it has been unclear what the role of
PIH in PPCM is. Indeed, many authors have described great variability in the prevalence of PIH
in PPCM, with preeclamptic patients accounting from 15 to 89% of PPCM patients reported in
the different studies [5–8, 11–16]. It is has been suggested that the inclusion of patients with
varying degrees of gestational hypertension, in the index as well as previous pregnancies, has
contributed significantly to the discrepancy in reported characteristics of PPCM [2,3,17].
We have performed a study of the clinical characteristics and outcome of a consecutive
series of patients with a new diagnosis of pregnancy-associated heart failure occurring in the
last trimester of pregnancy or puerperium in Cape Town. The study was conducted during a
period of great social and epidemiological transition in South Africa, shortly after the introduc-
tion of democracy. We investigated whether there were significant differences in time of onset
of symptoms, clinical profile, and outcome between HHFP cases compared to patients with
unexplained PPCM, in order to assess whether they can be considered to be a spectrum of the
same disease, or whether they should be classified differently.
Methods
Study design
This is a prospective, longitudinal hospital-based case-comparison study of HHFP to PPCM,
in patients presenting with heart failure between the last month of pregnancy and the fifth
postpartum month, who had been referred to the Cardiac Clinic at Groote Schuur Hospital in
Cape Town, South Africa.
We invited clinicians to refer patients with a new diagnosis of heart failure occurring in the
last trimester or puerperium for enrollment into a study of risk factors of PPCM. The exclusion
criteria were a known cardiac lesion; in particular, valvular heart disease, previous anthracycline
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exposure, ischaemic heart disease, a congenital heart lesion, and metabolic and systemic disor-
ders with cardiovascular sequelae including diabetes mellitus and thyroid disease. Patients with
any form of hypertension in pregnancy (including PIH) were included in the study; the latter
patients were classified as HHFP. The study participants were evaluated by one physician
(BMM) consecutively between February 1, 1996 and December 31, 2009 in a specialist cardio-
myopathy clinic. The median follow-up for PPCM was 3.5 years and 6 years for HHFP.
Definition of HHFP and PPCM
The diagnosis of HHFP was based on the presence of clinical heart failure associated with any
form of hypertension (i.e., chronic hypertension, gestational proteinuric hypertension, pre-
eclampsia, eclampsia and postpartum hypertension), occurring in women between the last
month of pregnancy and the first 5 months of the postpartum, in the absence of pre-existing
heart disease, and any other identifiable cause of peripartum heart failure besides hypertension.
Even though most of this group of study subjects had evidence of depressed systolic function
(LVEF less than 45%) shortly after delivery, on echocardiography, there was no restriction on
subject selection based on echocardiographic parameters.
The standard definition of PPCM was applied; the patients with PPCM needed to fulfill
echocardiographic criteria of a left ventricular ejection fraction (LVEF) below 45%, left ventric-
ular fractional shortening below 28%, and a left ventricular end diastolic dimension greater
than 5.5cm or greater than 2.7cm/m2 [1]. Patients with any form of hypertension, preeclampsia
or eclampsia were excluded from the PPCM group.
Data collection
There were 36 patients with PPCM that were enrolled in the study and 6 of these were subse-
quently lost to follow-up, and were not included in the analysis. All patients with a diagnosis of
HHFP were included in the analysis. All patients had comprehensive clinical assessment, com-
plemented by chest radiography, electrocardiography (ECG), two-dimensional and Doppler
colour-flow echocardiography, and cardiac catheterisation, when appropriate. Blood was taken
for full blood count, serum creatinine, urea and electrolytes. The primary imaging modality
used to confirm the diagnosis was transthoracic two-dimensional and Doppler echocardiogra-
phy. As the analysis period for the study is over 14 years, the echocardiographic assessments
were performed by different cardiologists and sonographers at different time points in the fol-
low-up, and some of these echocardiographic studies were incomplete. In the end, we were
able to establish the vital status of 30 PPCM and 53 HHFP patients at the end of the follow-up
period.
Statistical analysis
Results of quantitative measurements are given as means ± SD. Categorical traits are repre-
sented as number and percentage. Pearson’s chi-square or Fisher’s exact test were used to com-
pare the relative frequency of characteristics between the two groups of patients. All P values
are two-sided; and P values< 0.05 are considered to be statistically significant. Survival analy-
sis was performed using Kaplan-Meier plots.
Ethics statement
This study was approved by the University of Cape Town Faculty of Health Sciences Human
Research Ethics Committee. All patients gave informed consent for participation in the study,
and the study complies with the Declaration of Helsinki.
Hypertensive Heart Failure of Pregnancy and Peripartum Cardiomyopathy
PLOS ONE | DOI:10.1371/journal.pone.0133466 August 7, 2015 3 / 13
Results
Baseline characteristics
A total of 83 female patients were included in this study (Table 1). PPCM patients had an aver-
age age of 31.5 ± 7.5 years and HHFP patients had a similar mean age of 29.6 ± 6.6 years
(p = 0.223). Nine (30%) of PPCM patients developed heart failure in the first week after deliv-
ery, 7 (23.3%) after the first week but before the end of the first postpartum month, and 14
(46.7%) after the first month, but before the end of fifth postpartum month. In contrast, the
HHFP patients presented earlier, with 45 (84.9%) developing heart failure in the last month of
pregnancy, 6 (11.3%) in the first postpartum week, and 2 (3.8%) between the first and fifth
postpartum months (p<0.001) (Fig 1). Twin pregnancy occurred more commonly in PPCM
patients (p = 0.044), as did smoking (p = 0.024). A family history of hypertension (p<0.001)
and a history of hypertension in a previous pregnancy (p<0.001) were found more commonly
in HHFP patients.
Clinical characteristics at presentation
Three (10%) of the PPCM patients and 6 (11.3%) of the HHFP patients were HIV-infected
(p = 0.582). The systolic and diastolic blood pressures measurements were 105.9 ± 16.2 mmHg
and 63.5 ± 9.6 mmHg in PPCM patients and 162.3 ± 28.4 mmHg and 105.0 ± 12.1 mmHg in
HHFP patients (p = 0.003 and p<0.001, respectively). Basal rales were detected in 16 (53.3%)
of PPCM patients and 41 (77.4%) of HHFP patients (p = 0.007). Peripheral oedema was pres-
ent in 80% of PPCM patients compared to 35.8% of HHFP patients (p<0.001).
Radiographic, electrocardiographic, and echocardiographic features
A cardiothoracic ratio (CTR) greater than 50% was found more commonly in PPCM compared
to HHFP patients (p<0.001) (Table 2). Radiographic evidence of pulmonary oedema was
noted more frequently in HHFP patients, in keeping with the clinical detection of rales
(p = 0.010). Higher heart rate was found in HHFP patients (p = 0.014). On electrocardiography
(ECG), atrial fibrillation (p = 0.028), QRS abnormalities (p = 0.001), relatively longer QRS
duration (p<0.001), left atrial hypertrophy (p = 0.030), and left bundle brunch block
(p = 0.002), and T wave inversion (p<0.001) were detected more commonly in PPCM patients
than in HHFP patients. As expected, left ventricular hypertrophy (LVH) (p = 0.021) was seen
more frequently in HHFP patients. On echocardiography, patients with HHFP had greater
ventricular septal thickness in diastole (p = 0.013) as well as greater LV posterior free wall
thickness in systole (p = 0.002). PPCM patients had larger LV dimensions both in systole and
diastole (p<0.001 and p<0.001, respectively), as well as lower LVEF and LV fractional shorten-
ing (p<0.001 and p<0.001, respectively) compared to HHFP patients.
Medical management at follow up
With regards to heart failure therapy, significantly more PPCM patients were receiving furose-
mide (p<0.001), angiotensin converting enzyme-inhibitor (ACE-I)/angiotensin receptor
blocker (ARB) (p<0.001), β-blockers (p<0.001), spironolactone (p<0.001) and digoxin
(p<0.001) compared to HHFP patients (Fig 2). However, more HHFP patients were on cal-
cium channel blockers (CCB) for treatment of hypertension than PPCM (p = 0.014). Warfarin
was prescribed more commonly for consequent atrial fibrillation, and LV thrombus for PPCM
patients (p = 0.030).
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Survival analysis
There were 5 deaths in PPCM patients during the 14 years of follow-up, while there were no
deaths in the HHFP group (p = 0.005). A Kaplan-Meier analysis of survival stratified according
to PPCM versus HHFP at last follow-up visit (p<0.001) is shown in Fig 3. Table 3 shows that
chronic heart failure was more common in PPCM patients at the last follow-up visit
(p<0.001). Similarly, intra-cardiac thrombus (p = 0.014) and development of pulmonary
Table 1. Clinical characteristics of patients with peripartum cardiomyopathy (PPCM) and hypertensive heart failure of pregnancy (HHFP) at the ini-
tial presentation with heart failure.
Clinical characteristics PPCM (N = 30) HHFP (N = 53*) P-value
Ethnicity: 0,820
Black/African 18 (60.0) 30 (56.6)
Coloured/Mixed ancestry 12 (40.0) 23 (43.4)
Age at diagnosis 31.5 ± 7.5 29.6 ± 6.6 0.223
Onset of symptoms in relation to pregnancy: <0.001
Last trimester 0 (0) 45 (84.9)
Within 1st week after delivery 9 (30.0) 6 (11.3)
> 1st week,<1st month after delivery 7 (23.3) 0 (0)
> 1st month,<5th month after delivery 14 (46.7) 2 (3.8)
Twin pregnancy 3 (10.0) 0 (0) 0.04
Family history of hypertension 3 (10.0) 35 (66.0) <0.001
History of hypertension in previous pregnancy 0 (0) 17 (32.1) <0.001
NYHA FC at presentation: 0,163
Class I and II 10 (33.3) 9 (16.9)
Class III and IV 20 (66.7) 44 (83.1)
Pedal oedema 24 (80.0) 19 (35.8) <0.001
Parity 2.4 ± 0.7 2.2 ± 0.6 0.591
Gravidity 2.4 ± 0.7 2.2 ± 0.6 0.595
Smoking: 0,24
Never smoker 21 (70.0) 33 (62.3)
Former smoker 2 (6.7) 15 (28.3)
Current smoker 7 (23.3) 5 (9.4)
Alcohol: 0,244
Never drinker 23 (76.7) 45 (89.4)
Former drinker/moderate use 4 (13.3) 7 (13.2)
Excessive intake 3 (10.0) 1 (1.9)
HIV seropositive 3 (10.0) 6 (11.3) 0.582
Delay from symptom onset to clinical assessment (months) 2.7 ± 1.4 1.1 ± 0.3 <0.001
Systolic blood pressure 105.9 ± 16.2 162.3 ± 28.4 0.003
Diastolic blood pressure 63.5 ± 9.6 105.0 ± 12.1 <0.001
Basal rales 16 (53.3) 41 (77.4) 0.007
Murmur: 0,006
No murmur 10 (33.3) 35 (66.0)
MR 13 (43.3) 14 (24.6)
MR + TR 7 (23.3) 3 (5.7)
ESM 0 (0) 1 (1.9)
(*48 [90.6%] of the 53 HHFP patients had a diagnosis of preeclampsia; NYHA FC = New York Heart Association functional class; MR, mitral regurgitation;
TR, tricuspid regurgitation; ESM, ejection systolic murmur).
doi:10.1371/journal.pone.0133466.t001
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hypertension (p = 0.022) were commoner in PPCM patients. At the most recent hospital visit,
18 (72.0%) of PPCM patients were in NYHA functional class I and II and 7 (28.0%) were in
functional class III and IV compared to 52 (98.1%) of HHFP patients with class I and II symp-
toms and 1 (1.9%) with class III and IV symptoms (p<0.001).
Discussion
We present the results of a case comparison study of the clinical features and outcome of preg-
nancy-associated heart failure with or without hypertension in patients with no history of
structural heart disease and show that in our centre unexplained peripartum cardiomyopathy
is exclusively a postpartum disease that is associated with distinct clinical features of heart mus-
cle disease (such as left bundle branch block and atrial fibrillation), chronic heart failure, and a
fatal outcome in a proportion of cases. By contrast, HHFP is predominantly an antepartum dis-
ease that presents mainly with pulmonary oedema, left ventricular hypertrophy, and a revers-
ible form of heart failure in the overwhelming majority of cases.
We have found that PPCM to be a postpartum condition, with 53% of PPCM patients pre-
senting within the first month of the puerperium and the other 47% presenting within the sub-
sequent four postpartum months, in contrast to HHFP, where 85% of patients presented with
heart failure in the last month before delivery. Our findings are similar to those of another
Fig 1. Onset of heart failure symptoms in hypertensive heart failure of pregnancy and peripartum cardiomyopathy.
doi:10.1371/journal.pone.0133466.g001
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South African study which found that heart failure symptoms develop in the postpartum
period in 100% of PPCM patients [18]. Summarising pooled data from 419 cases of PPCM,
Lampert and Lang, demonstrated that 78% of PPCM cases developed symptoms in the first
four months postpartum, while 9% had their onset of symptoms in the last antepartum month,
and 13% either developed symptoms before one month antepartum or after four months post-
partum [19]. In the main, however, studies comprising a greater proportion of patients with
preeclampsia have documented greater frequency of onset of PPCM in the last month of preg-
nancy [20,21]. By comparison, studies with fewer cases of pregnancy-associated hypertension
have reported a largely postpartum onset of PPCM [2,5,8,22].
A family history of hypertension was found more commonly in HHFP patients compared
to PPCM patients; and in this study, a history of previous hypertension in pregnancy was pres-
ent in a third of patients with HHFP and absent in those with PPCM. Genetic factors play a
role in the development of pregnancy-induced hypertension (PIH), with both maternal and
paternal genetic contributions being important [23,24]. Genetic predisposition to PIH/pre-
eclampsia is suggested by the observation that primigravid women with a family history of pre-
eclampsia (i.e., affected mother or sister) have a 2- to 5-fold increased risk of developing the
disease than primigravid women without such a history [25]. Furthermore, the spouse of men
who are the product of a pregnancy complicated by preeclampsia are more likely to develop
preeclampsia than spouses of men without such a history [26].
Features of congestive heart failure (pedal oedema, elevated jugular venous pressure, and
basal rales) were found in up to 80% of PPCM patients, but only in 35.8% of HHFP patients at
presentation. In contrast, isolated pulmonary oedema was one of the main clinical and radio-
logic findings in patients with HHFP in this study. The association of PIH/preeclampsia with
isolated pulmonary oedema is well-established [27,28]. Differences in clinical presentation
between PPCM and HHFP may also be partly explained on the basis of volume overload in
HHFP patients with systolic and diastolic dysfunction [29]. The pathophysiology of pulmonary
oedema in preeclampsia is unclear, but is presumed to be due to a combination of
Table 2. Radiologic, electrocardiographic, and echocardiographic findings at initial presentation with heart failure.
Radiologic, electrocardiographic, echocardiographic and laboratory findings PPCM (N = 30) HHFP (N = 53) P-value
Radiographic cardiothoracic ratio>50% 29 (96.7) 22 (41.5) <0.001
Radiographic pulmonary oedema 16 (53.3) 45 (89.4) 0.010
ECG heart rate 86.3±17.8 106.9±27.4 0.014
ECG QRS abnormalities 8 (27.6) 1 (1.9) 0.001
ECG voltage abnormality 8 (27.6) 31 (58.5) 0.816
ECG left anterior hemiblock 9 (30.0) 5 (9.4) 0.03
ECG Q wave 5 (16.7) 5 (9.4) 0.484
ECG left bundle branch block 6 (20.0) 0 (0) 0.002
ECG Left ventricular hypertrophy 8 (26.7) 29 (54.7) 0.021
ECG T wave inversion 22 (73.3) 13 (24.5) <0.001
Atrial fibrillation 3 (10.0) 0 (0) 0.028
QRS duration 109.5±12.17 89.8±10.26 <0.001
Echo interventricular septum (diastole) 0.9 ± 0.2 1.2 ± 0.2 0.013
Echo LV posterior wall (systole) 1.2 ± 0.3 1.4 ± 0.3 0.002
Echo LV end-systolic diameter (diastole) 6.8 ± 0.7 3.5 ± 0.6 <0.001
Echo LV end-diastolic dimension (diastole) 7.4 ± 1.1 5.1 ± 0.9 <0.001
Echo LV ejection fraction 23.8 ± 8.3 49.9 ± 18.7 <0.001
Echo LV fractional shortening 11.6 ± 4.1 26.2 ± 3.2 <0.001
doi:10.1371/journal.pone.0133466.t002
Hypertensive Heart Failure of Pregnancy and Peripartum Cardiomyopathy
PLOS ONE | DOI:10.1371/journal.pone.0133466 August 7, 2015 7 / 13
microangiopathy, capillary leak and sometimes iatrogenic fluid overload [30]. PPCM, on the
other hand, results from development of primary myocardial dysfunction leading to congestive
heart failure [3,4], and has been shown recently, in a mouse model, to be associated with defec-
tive cathepsin-D mediated cleavage of prolactin into a 16-kDa form, which is both pro-apopto-
tic and anti-angiogenic [31]. PPCMmay also have genetic underpinnings, and recent reports
have supported the contention that PPCMmay be part of familial dilated cardiomyopathy
[32,33].
Multiple differences were noted on ECG in the comparison between PPCM and HHFP.
First, LVH was found to occur more commonly in HHFP than in PPCM. PIH represents a
model of acute pressure overload that may induce dramatic changes in left ventricular structure
and function [34]. Other important ECG findings from our study included the observation
that QRS abnormalities, left atrial hypertrophy, left bundle branch block (LBBB), atrial fibrilla-
tion, non-specific T wave inversion and longer QRS duration occurred more frequently in
patients with PPCM compared to those with HHFP. Similar findings have been reported previ-
ously: repolarisation changes have been reported in 47.3% [35] and left bundle branch block to
occur in 10% of PPCM patients [36]. Davidson and Parry found arrhythmias in 2%, and LBBB
in 5% of patients with peripartum heart failure, while LVH was present in 26% and T wave
changes found in 15% [37]. In a study of 97 PPCM patients from South Africa, LVH was dem-
onstrated in 66% and ST segment and T wave abnormalities noted in 96% [38]. These ECG
Fig 2. Use of medication at follow-up.
doi:10.1371/journal.pone.0133466.g002
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Fig 3. Kaplan-Meier survival plot for hypertensive heart failure of pregnancy and peripartum cardiomyopathy patients over 14 years.
doi:10.1371/journal.pone.0133466.g003
Table 3. Survival and status at last follow-up for the PPCM and HHFP patients studied.
PPCM (N = 30) HHFP (N = 53) P-value
Median duration of follow-up 3.5 years 6 years 0.02
Death 5 (16.7) 0 (0) 0.005
Chronic heart failure 24 (80.0) 8 (15.1) <0.001
Cardiac resynchronization therapy 1 (3.3) 0 (0) 0.361
Intracardiac thrombus 5 (16.7) 0 (0) 0.014
Stroke 2 (6.7) 0 (0) 0.128
Pulmonary hypertension 4 (13.3) 1 (1.9) 0.022
Heart transplantation 1 (3.3) 0 (0) 0.361
NYHA FC at last visit: <0.001
Class I and II 18 (72.0) 52 (98.1)
Class III and IV 7 (28.0) 1 (1.9)
NYHA FC, New York Heart Association Functional Class.
doi:10.1371/journal.pone.0133466.t003
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changes are associated with increased cardiovascular morbidity and mortality in patients with
impaired LV function, and QRS duration has been shown to be strongly associated with atrial
fibrillation and adverse outcome in patients with cardiomyopathy [39]. The electrocar-
diographic findings in our study may signify greater myocardial injury in patients with PPCM
compared to those with HHFP. While the ECG of most women with PPCM is usually abnor-
mal [2,40–43], there are no ECG changes that are sufficiently sensitive or specific for the diag-
nosis of PPCM [20], nor are there ECG characteristics that serve as a differentiator between
PPCM and HHFP.
A higher heart rate and blood pressure were found in patients with HHFP compared to
those with PPCM. The finding of increased and/or highly variable pulse rates and elevated arte-
rial pressures in PIH/preeclampsia has been described, and is thought to partly reflect dis-
turbed neural control of heart rate and blood pressure, as a result of impaired sympathetic and
parasympathetic nervous system activity in PIH [44]. Maladaptation of the maternal cardiovas-
cular system in PIH/preeclampsia is manifested as a lack of physiological decline in cardiovas-
cular oscillations of heart rate and blood pressure [45].
On echocardiography, we found the interventricular septum (IVS) thickness and left ven-
tricular posterior free wall (LVPW) thickness to be increased in HHFP compared to PPCM,
likely reflecting left ventricular adaptation to increased wall stress from elevated blood pressure.
Similarly, IVS and LVPW thickness were increased in PIH/preeclampsia patients compared
with normal controls [46]. PIH was associated with an abnormal left ventricular (LV) geomet-
ric pattern in 62% of 106 patients studied, of which 42% had eccentric hypertrophy, 17% had
concentric remodeling, and 5% had concentric hypertrophy [47]. Again, likely reflecting
greater myocardial injury, the LVEF and LV fractional shortening were lower in PPCM
patients and were associated with increased LV dimensions in systole and diastole. Similarly,
demonstrating impaired LV function (i.e., depressed LVEF, LV cardiac output and stroke vol-
ume) and increased LV dimensions have been reported in PPCM by many authors [2,6–8].
Furthermore, the LVEF and LVEDD have been correlated with outcome in PPCM [16,48], but
not in this study.
Finally, we showed that morbidity and mortality was higher in PPCM, with lack of full
recovery of cardiac function (average LVEF 23.8% at diagnosis and 31.3% at last follow-up),
compared to HHFP patients (average LVEF 49.9% at diagnosis and 68.2% at last follow-up).
Similar findings have recently been made by Kamiya and colleagues who examined the clinical
profile of Japanese PPCM patients with and without gestational hypertension and found that
patients with pregnancy-associated hypertension diagnosed with PPCM had a shorter hospital-
ization and higher LVEF at last follow-up when compared to the PPCM patients without
hypertension [48]. The mortality for PPCM of 17% over a median of 3.5 years of follow-up is
similar to that seen in other countries such as Haiti and Turkey, but much higher than the
United States [17]. Chronic heart failure, intra-cardiac thrombus, thrombo-embolic phenom-
ena and pulmonary hypertension occurred with greater frequency in patients diagnosed with
PPCM. These grave sequelae have been previously reported on in PPCM, and shown to be
associated with increased mortality [4,7,16,49]. However, the seriousness of HHFP should not
be under-estimated: a recent report on maternal deaths from South Africa showed that pre-
eclampsia/eclampsia and proteinuric hypertension accounted for 83.1% of all PIH-related
deaths, and that HHFP was the cause of death in 22.8% of PIH-related deaths in the same
period [50].
The data from this study show that there are significant differences in the time of onset of
heart failure, clinical characteristics, and outcomes of patients with HHFP compared to those
with truly unexplained PPCM. Hence, these data support the proposal that a history or pres-
ence of hypertension in pregnancy should exclude the diagnosis of PPCM, as the two appear to
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be distinct clinical conditions [2,3,10]. However, this study has a number of limitations includ-
ing small sample size, being from a single centre, differences in follow-up duration between
HHFP and PPCM patients, lack of repeat echocardiography in the majority of HHFP patients
at follow-up and the lack of information about repeat pregnancies and the potential for confu-
sion between the symptoms of heart failure and the often similar symptoms of normal preg-
nancy. It is also important to highlight that, by its very nature, a specialist clinic in a tertiary
referral center has a selection bias for the cases that develop chronic PPCM, and may miss
cases that demise acutely. Finally, we acknowledge that using strict cut-offs for case definition
of PPCMmay have led to an underestimate of its prevalence in our setting.
Despite these limitations, this work may contribute to the clarification of the case definition
of PPCM by excluding patients with any form of hypertension in this group. We show that
HHFP is predominantly an antepartum disease that presents mainly with pulmonary oedema,
left ventricular hypertrophy, and a reversible form of heart failure in the overwhelming major-
ity of cases. By contrast, at our centre, unexplained PPCM is exclusively a postpartum disease
that is associated with distinct clinical features of heart muscle disease (such as left bundle
branch block and atrial fibrillation), chronic heart failure, and a fatal outcome in a proportion
of cases. Large prospective multicenter studies of peripartum heart failure with and without
hypertension are required to confirm the findings of this study.
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